A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
Tongji Medical College of Huazhong University of Science and Technology is a prestigious medical school with a history of more than 110 years. It is one of the birthplaces of modern medical education in China. It is one of the first 10 medical colleges and universities under the Ministry of Education and National Health Planning Commission First, it is the first batch of eight-year medical education colleges in the country to be piloted, and it is the first batch of nationwide outstanding doctor education training plan implementation colleges.
Wuhan, China Clinical Trial Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Jiang’an District, 三阳路